Ritchie DS - Search Results

1

Complete molecular response of e6a2 BCR-ABL-positive acute myeloid leukemia to imatinib then dasatinib.

Ritchie DS, McBean M, Westerman DA, Kovalenko S, Seymour JF, Dobrovic A. Ritchie DS, et al. Blood. 2008 Mar 1;111(5):2896-8. doi: 10.1182/blood-2007-08-107508. Epub 2007 Dec 11. Blood. 2008. PMID: 18073350 Free article.

2

Acute left ventricular failure following melphalan and fludarabine conditioning.

Ritchie DS, Seymour JF, Roberts AW, Szer J, Grigg AP. Ritchie DS, et al. Bone Marrow Transplant. 2001 Jul;28(1):101-3. doi: 10.1038/sj.bmt.1703098. Bone Marrow Transplant. 2001. PMID: 11498753

3

Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies.

Tam C, Seymour JF, Brown M, Campbell P, Scarlett J, Underhill C, Ritchie D, Bond R, Grigg AP. Tam C, et al. Haematologica. 2005 May;90(5):700-2. Haematologica. 2005. PMID: 15921393

4

The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma.

Ritchie DS, Seymour JF, Grigg AP, Roberts AW, Hoyt R, Thompson S, Szer J, Prince HM. Ritchie DS, et al. Ann Hematol. 2007 Feb;86(2):101-5. doi: 10.1007/s00277-006-0193-2. Epub 2006 Nov 7. Ann Hematol. 2007. PMID: 17089127 Clinical Trial.

5

The Late Effects Clinic in action: for survivors of childhood malignancy.

Campbell BA, Wheeler G, Seymour JF, Ritchie D, Goroncy N. Campbell BA, et al. Acta Oncol. 2007;46(8):1152-8. doi: 10.1080/02841860701426815. Acta Oncol. 2007. PMID: 17851871

6

[18F]fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphoma.

Gill S, Wolf M, Prince HM, Januszewicz H, Ritchie D, Hicks RJ, Seymour JF. Gill S, et al. Clin Lymphoma Myeloma. 2008 Jun;8(3):159-65. doi: 10.3816/CLM.2008.n.019. Clin Lymphoma Myeloma. 2008. PMID: 18650179

7

Predicting durable remissions following thalidomide therapy for relapsed myeloma.

Quach H, Mileshkin L, Seymour JF, Milner A, Ritchie D, Harrison S, Westerman D, Prince HM. Quach H, et al. Leuk Lymphoma. 2009 Feb;50(2):223-9. doi: 10.1080/10428190802663213. Leuk Lymphoma. 2009. PMID: 19194832 Clinical Trial.

8

The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy.

Gill S, Carney D, Ritchie D, Wolf M, Westerman D, Prince HM, Januszewicz H, Seymour JF. Gill S, et al. Ann Oncol. 2010 Feb;21(2):331-334. doi: 10.1093/annonc/mdp297. Epub 2009 Jul 22. Ann Oncol. 2010. PMID: 19625344 Free article.

9

Mantle cell lymphoma with central nervous system involvement: frequency and clinical features.

Gill S, Herbert KE, Prince HM, Wolf MM, Wirth A, Ryan G, Carney DA, Ritchie DS, Davies JM, Seymour JF. Gill S, et al. Among authors: ritchie ds. Br J Haematol. 2009 Oct;147(1):83-8. doi: 10.1111/j.1365-2141.2009.07835.x. Epub 2009 Aug 19. Br J Haematol. 2009. PMID: 19694718 Free article.

10

The role of ancestim (recombinant human stem-cell factor, rhSCF) in hematopoietic stem cell mobilization and hematopoietic reconstitution.

Herbert KE, Prince HM, Ritchie DS, Seymour JF. Herbert KE, et al. Among authors: ritchie ds. Expert Opin Biol Ther. 2010 Jan;10(1):113-25. doi: 10.1517/14712590903473123. Expert Opin Biol Ther. 2010. PMID: 19947895 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters